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Conclusions: Early post-operative hypophosphatemia is an
independent predictor of LRC. A simple LRC risk prediction
tool that includes this variable accurately identified low-risk
patients and may help identify those most likely to benefit
from enhanced postoperative recovery pathways.
OP-I.46 SURVIVAL FOLLOWING
PANCREATICODUODENECTOMY
FOR STAGE 1A PANCREATIC
ADENOCARCINOMA IS NOT IMPROVED
BY MULTIMODALITY TREATMENT
K. T. Ostapoff, P. Thirunavukarasu, B. W. Kuvshinoff,
S. J. Nurkin, S. N. Hochwald
Roswell Park Cancer Institute, Buffalo, NY
Introduction: Pancreaticoduodenectomy is an integral part
of pancreatic adenocarcinoma treatment. NCCN guidelines
recommend patients undergo multimodality therapy, but few
studies validate its significance in early stage patients.
Methods: Using NCDB from 1998–2006, patients who
underwent a pancreaticoduodenectomy were identified.
Patients with invasive histology and stage 1 disease were
included. X2 test was used for categorical variables. Median
survival was estimated using Kaplan-Meier method with log-
rank comparison and Cox regression.
Results: Over 8 years, 2,801 patients were identified.
Median overall survival for Stage 1A (n = 1047) and Stage
1B (n = 1776) was 31.8 and 23.2 months with a median
overall follow-up of 23.7 months (0–172.9). Stage 1B
patients were more likely to have higher grade tumors
(p = 0.002), receive chemotherapy (p = 0.007) or radiation
(p = 0.002) and have positive margins (p < 0.0001). There
were no differences between groups with respect to lymph
node yield (LN) or type of treatment facility. For both stages,
chemotherapy, radiation, LN yield ≥17 nodes, age <70,
tumor grade and facility type were associated with an
improved overall survival on univariate analysis. However on
multivariate analysis, for Stage 1A patients only LN yield
≥17 was independently predictive of survival while chemo-
therapy, radiation, facility type, age and sex had no impact on
survival. For patients with Stage 1B, chemotherapy, age <70
and LN harvest ≥17 were associated with an improved
overall survival on multivariate analysis.
Conclusion: Despite guidelines recommending multi-
modality treatment for pancreatic adenocarcinoma, there is no
improvement in survival for patients with Stage 1A disease. A
surgery only approach should be considered for these patients.
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CENTRAL PANCREATECTOMY WITH
PANCREATIGOGASTROSTOMY FOR
HIGH RISK CYSTIC NEOPLASM
L. Schwarz, J. B. Fleming, M. H. Katz, J. E. Lee,
T. A. Aloia, J. Vauthey, C. H. Conrad
UT MD Anderson Cancer Center, Department Of Surgical
Oncology, Houston, TEXAS
Background: Organ-sparing pancreatic resection is impor-
tant in prophylactic surgery for cystic neoplasms. There is
controversy regarding the optimal surgical approach for pan-
creatic lesions in the neck or proximal body of the pancreas.
Central compared to distal pancreatectomy is technically
more challenging but preserves more functional pancreatic
tissue. Due to the prophylactic nature of the surgery and long
survival of patients with benign and borderline malignant
lesions, surgeons need to stratify greater importance to sur-
gical morbidity and sparing pancreatic parenchyma.
Patient: The patient is a 59-year-old active woman with a
symptomatic cystic neoplasm of the pancreas exhibiting high
risk imaging features. The cyst of 2.2 × 1.8 cm in the body of
the pancreas was impinging on the portal venous confluence.
Technique: The patient was positioned in the French Posi-
tion, the lesser sac was opened and the pancreatic body
exposed. A retropancreatic tunnel was created with staple
division of the neck. The body was mobilized off the
portal vein and splenic vessels transected. A retrogastric
pancreaticogastrostomy was sewn through an anterior
gastrotomy. The stent was delivered past the pylorus to
decrease pancreatic enzymatic activation.
Conclusion: Laparoscopic ultrasound helps in defining cyst
borders and minimal blood loss optimizes visualization
during the dissection. A minimally invasive pancreati-
cogastrostomy created through an anterior gastrotomy is
technically feasible and safe. This approach can minimize the
morbidity of prophylactic pancreatic surgery for patients with
cystic neoplasms. Nevertheless, it should not compromise
safety, oncologic completeness or an organ-sparing approach.
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